Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
5.58B | 5.53B | 5.49B | 5.08B | 4.40B | 5.44B | Gross Profit |
1.04B | 962.98M | 982.32M | 800.84M | 760.14M | 919.00M | EBIT |
243.49M | 188.87M | 161.29M | 17.58M | 30.17M | 48.00M | EBITDA |
354.59M | 343.22M | 314.86M | 204.11M | 205.47M | 204.00M | Net Income Common Stockholders |
149.57M | 133.30M | 79.54M | 2.34M | 4.26M | -23.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
610.00M | 622.10M | 422.49M | 569.06M | 636.12M | 615.00M | Total Assets |
5.31B | 5.36B | 5.60B | 5.23B | 5.31B | 5.46B | Total Debt |
2.26B | 2.33B | 2.80B | 2.57B | 2.90B | 2.82B | Net Debt |
1.65B | 1.71B | 2.38B | 2.00B | 2.26B | 2.20B | Total Liabilities |
3.84B | 3.99B | 4.34B | 4.05B | 4.10B | 4.26B | Stockholders Equity |
1.47B | 1.37B | 1.26B | 1.18B | 1.16B | 1.15B |
Cash Flow | Free Cash Flow | ||||
0.00 | 706.01M | -372.31M | 254.34M | -69.87M | -17.00M | Operating Cash Flow |
0.00 | 761.81M | -165.68M | 367.61M | 175.34M | 193.00M | Investing Cash Flow |
0.00 | -61.70M | -204.81M | -83.50M | -223.43M | -194.00M | Financing Cash Flow |
0.00 | -500.50M | 223.92M | -351.18M | 68.64M | 26.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥2.00B | 14.19 | 2.94% | 0.89% | 6.55% | ||
73 Outperform | ¥21.02B | 10.61 | 3.43% | 7.59% | 12.32% | ||
72 Outperform | ¥1.52B | 6.69 | 3.15% | -1.56% | -24.77% | ||
71 Outperform | ¥11.46B | 10.12 | 2.09% | 10.47% | 48.78% | ||
66 Neutral | $4.49B | 12.28 | 5.32% | 248.53% | 4.08% | -12.00% | |
65 Neutral | ¥2.30B | 28.76 | 2.52% | -3.66% | -72.39% |